205-500-4

应用筛选条件

关键词:'205-500-4'

显示 1-3 共 3 条结果关于 "205-500-4" 范围论文

Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.

Sarah A Buckley et al.

American journal of hematology, 89(4), 423-428 (2014-01-03)

Intensive chemotherapy for newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) is associated with significant treatment-related morbidity and mortality. Herein, we investigate how pretreatment characteristics relate to early adverse outcomes in such patients, studying 205 consecutive individuals receiving

Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study.

Gregory Feldman et al.

BMC pulmonary medicine, 10, 11-11 (2010-03-10)

Indacaterol is a novel, once-daily (o.d.) inhaled, long-acting beta2-agonist in development for chronic obstructive pulmonary disease (COPD). This 12-week, double-blind study compared the efficacy, safety, and tolerability of indacaterol to that of placebo in patients with moderate-to-severe COPD. Efficacy variables

Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.

Edward D Javor et al.

Diabetes, 54(7), 1994-2002 (2005-06-29)

Ectopic fat accumulation has been implicated as a contributing factor in the abnormal metabolic state of obesity. One human model of ectopic fat deposition is generalized lipodystrophy. Generalized lipodystrophy is a rare disorder characterized by a profound deficiency of adipose

1/1